IDEXX beats Q1 earnings and revenue forecasts, raises 2021 guidance

IDEXX Laboratories Inc. (Nasdaq: IDXX) on Tuesday posted first-quarter results that surpassed market forecasts and raised its 2021 outlook to reflect expectations for higher organic revenue growth and better operating margins.

The Westbrook-based provider of veterinary diagnostics, veterinary practice software and water microbiology testing said that first-quarter revenue was $778 million, an increase of 24% on a reported basis and 21% higher organically over a year earlier. That exceeded the consensus forecast of analysts polled by Zacks Investment Research by 5.87%. Read more

Related Posts

On the Record: Startup aims to turn scientific researchers into ‘deep-tech’ entrepreneurs

Justin Hafner, founder and former CEO of digital health startup Kinotek, aims to make an even bigger splash in the startup world...

3 November 2025

Skincare startup funds UMaine scholarship to spark innovation

Marin Skincare, known for its Lobster Lotion product, partnered with the University of Maine to create a scholarship to spur innovation and...

29 October 2025

Bigelow Lab looks to create ‘blue’ biotechnology businesses and jobs

Bigelow Laboratory for Ocean Sciences, an East Boothbay nonprofit research institute focused on global ocean health, last week launched a program...

28 October 2025